An Orthotopic Implantation Mouse Model of Hepatocellular Carcinoma with Underlying Liver Steatosis.

TitleAn Orthotopic Implantation Mouse Model of Hepatocellular Carcinoma with Underlying Liver Steatosis.
Publication TypeJournal Article
Year of Publication2020
AuthorsKasashima H, Duran A, Cid-Diaz T, Kudo Y, Diaz-Meco MT, Moscat J
JournalSTAR Protoc
Volume1
Issue3
Pagination100185
Date Published2020 Dec 18
ISSN2666-1667
Abstract

This protocol provides the steps required for a mouse liver orthotopic implantation model. The reliable pre-clinical animal models that have similar characteristics to hepatocellular carcinoma (HCC) are a powerful tool to unveil the mechanisms controlling tumor initiation and progression. Here, we describe a syngeneic orthotopic HCC model that recapitulates the role of a host pro-tumorigenic microenvironment by pre-conditioning mouse livers with a high-fat diet (HFD). For complete details on the use and execution of this protocol, please refer to Kudo et al. (2020).

DOI10.1016/j.xpro.2020.100185
Alternate JournalSTAR Protoc
PubMed ID33377079
PubMed Central IDPMC7757567
Grant ListP30 CA030199 / CA / NCI NIH HHS / United States
R01 CA211794 / CA / NCI NIH HHS / United States
R01 DK108743 / DK / NIDDK NIH HHS / United States
Related Faculty: 
Jorge Moscat, Ph.D. Maria Diaz-Meco Conde, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700